Have a personal or library account? Click to login
Increased intracellular and extracellular oxidant production in phagocytes of rheumatic patients treated with biological therapy – whole blood quantification Cover

Increased intracellular and extracellular oxidant production in phagocytes of rheumatic patients treated with biological therapy – whole blood quantification

Open Access
|Feb 2018

Abstract

Infectious complications, resulting from reduced activity of immune cells, are the most severe and common adverse effects of biological therapy. This study analyzed the effect of biological therapy on blood phagocytes, focusing on the formation of reactive oxygen species (ROS), an important factor in the defence against invading pathogens. Intra- and extracellular ROS production were recorded separately, on the basis of luminol and isoluminol chemiluminescence in patients treated with antibodies against tumor necrosis factor-α or against interleukin-6 receptor. In comparison to healthy donors or to rheumatic patients treated with classical immunosuppressive drugs, biological therapy increased ROS formation in both compartments. This indicates that the anti-microbial activity of blood phagocytes was not reduced by TNFα- or IL-6-neutralizing therapy, at least in terms of ROS.

The method presented does not require blood fractionation, which could modify activity of phagocytes and cause loss of some sub-populations of these cells. The technique is simple, requires microliter volumes of blood and is thus well applicable to clinical studies.

DOI: https://doi.org/10.1515/intox-2017-0008 | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Language: English
Page range: 52 - 55
Submitted on: Aug 16, 2017
Accepted on: Sep 12, 2017
Published on: Feb 14, 2018
Published by: Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2018 Viera Jančinová, Radomír Nosáľ, Juraj Payer, Zdenko Killinger, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.